Cited by 495Bacterial Cancer TherapyNanoparticle-Based Drug DeliveryGut microbiota and health

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Zheng, Di-Wei, Dong, Xue, Pan, Pei, Chen, Ke-Wei, Fan, Jin-Xuan, Cheng, Si-Xue, Zhang, Xian-Zheng·2019·Nature Biomedical Engineering

DOI 10.1038/s41551-019-0423-2

Open this paper in CoChat — free account

Abstract

The microbiota in the human gut is strongly correlated with the progression of colorectal cancer (CRC) and with therapeutic responses to CRC. Here, by leveraging the higher concentration of the pro-tumoural Fusobacterium nucleatum and the absence of antineoplastic butyrate-producing bacteria in the faecal microbiota of patients with CRC, we show that-in mice with orthotopic colorectal tumours or with spontaneously formed colorectal tumours-oral or intravenous administration of irinotecan-loaded dextran nanoparticles covalently linked to azide-modified phages that inhibit the growth of F. nucleatum significantly augments the efficiency of first-line chemotherapy treatments of CRC. We also show that oral administration of the phage-guided irinotecan-loaded nanoparticles in piglets led to negligible changes in haemocyte counts, immunoglobulin and histamine levels, and liver and renal functions. Phage-guided nanotechnology for the modulation of the gut microbiota might inspire new approaches for the treatment of CRC.

Integrity signals

Registry

Crossref · 10.1038/s41551-019-0423-2

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263

Show all 37 references

Sorted by citations

Gut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 779
Microbiome and cancer
Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.006 · Cited by 578
Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 571
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Host–microbiota maladaptation in colorectal cancer
Janney, A., Powrie, F., & Mann, E. H. (2020) · Nature · doi:10.1038/s41586-020-2729-3 · Cited by 445
Understanding and targeting resistance mechanisms in cancer
Lei, Z., Qin, T., Teng, Q., Wurpel, J. N. D., Zeng, L., Pan, Y., & Chen, Z. (2023) · MedComm · doi:10.1002/mco2.265 · Cited by 406
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer
Wang, N., & Fang, J. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.010 · Cited by 405
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
The oral–gut microbiome axis in health and disease
Kunath, B. J., Rudder, C. D., Laczny, C. C., Letellier, E., & Wilmes, P. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01075-5 · Cited by 372
Bacteria in cancer initiation, promotion and progression
Tekle, G. E., & Garrett, W. S. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 361
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Sánchez‐Alcoholado, L., Ramos‐Molina, B., Otero, A. P., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez‐Millán, J., & Queipo‐Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12061406 · Cited by 346
The Oral Microbiome and Cancer
Irfan, M., Delgado, R. Z. R., & Frias-Lopez, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591088 · Cited by 341
A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea
Pan, J., Gong, G., Wang, Q., Shang, J., He, Y., Catania, C., Birnbaum, D., Li, Y., Jia, Z., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29672-z · Cited by 323
The gut virome: A new microbiome component in health and disease
Cao, Z., Sugimura, N., Burgermeister, E., Ebert, M. P. A., Zuo, T., & Lan, P. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104113 · Cited by 303
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Ting, N. L.-N., Lau, H. C.-H., & Yu, J. Q. (2022) · Gut · doi:10.1136/gutjnl-2021-326264 · Cited by 297
Targeting the gut microbiota for cancer therapy
Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M., & Trinchieri, G. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00513-x · Cited by 290
Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer
Zheng, D., Li, R., An, J., Xie, T., Han, Z., Xu, R., Fang, Y., & Zhang, X. (2020) · Advanced Materials · doi:10.1002/adma.202004529 · Cited by 274
Self-citation
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System
Abed, J., Maalouf, N., Manson, A. L., Earl, A. M., Parhi, L., Emgård, J., Klutstein, M., Tayeb, S., Almogy, G., Atlan, K., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00400 · Cited by 274
Intratumoural microbiota: a new frontier in cancer development and therapy
Cao, Y., Xia, H., Tan, X., Shi, C., Ma, Y., Meng, D., Zhou, M., Lv, Z., Wang, S., & Jin, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01693-0 · Cited by 269
A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202207366 · Cited by 259
Phage-Guided Targeting, Discriminative Imaging, and Synergistic Killing of Bacteria by AIE Bioconjugates
He, X., Yang, Y., Guo, Y., Lu, S., Du, Y., Li, J., Zhang, X., Leung, N. L. C., Zhao, Z., Niu, G., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b12936 · Cited by 250
Self-citation
Nanotechnology intervention of the microbiome for cancer therapy
Song, W., Anselmo, A. C., & Huang, L. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0589-5 · Cited by 248
Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
Li, Z., Wang, Y., Liu, J., Rawding, P. A., Bu, J., Hong, S., & Hu, Q. (2021) · Advanced Materials · doi:10.1002/adma.202102580 · Cited by 247
Self‐Mineralized Photothermal Bacteria Hybridizing with Mitochondria‐Targeted Metal–Organic Frameworks for Augmenting Photothermal Tumor Therapy
Chen, Q., Liu, X., Fan, J., Peng, S., Wang, J., Wang, X., Zhang, C., Liu, C., & Zhang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909806 · Cited by 238
Self-citation
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
Wang, M., Rousseau, B., Qiu, K., Huang, G., Zhang, Y., Su, H., Bihan-Benjamin, C. L., Khati, I., Artz, O., Foote, M. B., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01957-8 · Cited by 226
Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment
Hanus, M., Parada‐Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Álvarez, K., Hermoso, M. A., López-Köstner, F., & la Fuente, M. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 208
Fusobacterium nucleatum and cancer
Alon‐Maimon, T., Mandelboim, O., & Bachrach, G. (2022) · Periodontology 2000 · doi:10.1111/prd.12426 · Cited by 203
Biomedical polymers: synthesis, properties, and applications
Chen, W., Chen, Q., Chen, Q., Cui, C., Duan, S., Kang, Y., Liu, Y., Liu, Y., Muhammad, W., Shao, S., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1243-5 · Cited by 197
Self-citation
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Li, Z., Xiong, W., Zhu, L. W., Wang, J., Zeng, Z., Kołat, D., Li, X., Zhou, D., Xu, X., & Zhao, L.-Y. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01541-w · Cited by 197
Cell primitive-based biomimetic functional materials for enhanced cancer therapy
Luo, G., Chen, W., Zeng, X., & Zhang, X. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00152j · Cited by 194
Self-citation
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Jain, T., Sharma, P., Are, A. C., Vickers, S. M., & Dudeja, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622064 · Cited by 187
A Comprehensive Review on Phage Therapy and Phage-Based Drug Development
Cui, L., Watanabe, S., Miyanaga, K., Kiga, K., Sasahara, T., Aiba, Y., Tan, X.-E., Veeranarayanan, S., Thitiananpakorn, K., Nguyen, H. M., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13090870 · Cited by 186
Gut microbiota shapes cancer immunotherapy responses
Lei, W., Zhou, K., Lei, Y., Li, Q., & Zhu, H. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00786-8 · Cited by 182
Recent advances in developing active targeting and multi-functional drug delivery systems via bioorthogonal chemistry
Yi, W., Xiao, P., Liu, X., Zhao, Z., Sun, X., Wang, J., Zhou, L., Wang, G., Cao, H., Wang, D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01250-1 · Cited by 178
Periodontitis: etiology, conventional treatments, and emerging bacteriophage and predatory bacteria therapies
Łasica, A. M., Golec, P., Laskus‐Perendyk, A., Zalewska, M., Gędaj, M., & Popowska, M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1469414 · Cited by 177
The microbial landscape of colorectal cancer
White, M., & Sears, C. L. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00973-4 · Cited by 173
Biomaterials coating for on-demand bacteria delivery: Selective release, adhesion, and detachment
Liu, J., Li, W., Wang, Y., Ding, Y., Lee, A., & Hu, Q. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101291 · Cited by 171
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities
Pandey, H., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Cancers · doi:10.3390/cancers15030866 · Cited by 171
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Lee, Y., Kamada, N., & Moon, J. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114021 · Cited by 169
Biomaterial-mediated modulation of oral microbiota synergizes with PD-1 blockade in mice with oral squamous cell carcinoma
Zheng, D., Deng, W., Song, W., Wu, C., Liu, J., Hong, S., Zhuang, Z., Cheng, H. L., Sun, Z., & Zhang, X. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00807-9 · Cited by 163
Self-citation
More Than Just a Periodontal Pathogen –the Research Progress on Fusobacterium nucleatum
Chen, Y., Huang, Z., Tang, Z., Huang, Y., Huang, M., Liu, H., Ziebolz, D., Schmalz, G., Jia, B., & Zhao, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.815318 · Cited by 154
Bacteriophages and their potential for treatment of gastrointestinal diseases
Duan, Y., Young, R., & Schnabl, B. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00536-z · Cited by 150
Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
Han, Z., Li, Y.-B., Yang, L., Cheng, H., Liu, X., & Chen, H. (2021) · Molecules · doi:10.3390/molecules27010137 · Cited by 145
Transforming Intratumor Bacteria into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer
Liu, X., Sun, M., Pu, F., Ren, J., & Qu, X. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09472 · Cited by 145
Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy
Lang, T., Zhu, R., Zhu, X., Yan, W., Li, Y., Zhai, Y., Wu, T., Huang, X., Yin, Q., & Li, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-40439-y · Cited by 133
Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer
Hou, Y., Jin, J., Duan, H., Liu, C., Chen, L., Huang, W., Gao, Z., & Jin, M. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121440 · Cited by 127
Intestinal phages interact with bacteria and are involved in human diseases
Shuwen, H., & Kefeng, D. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2113717 · Cited by 124
Towards a mechanistic understanding of reciprocal drug–microbiome interactions
Zimmermann, M., Patil, K. R., Typas, A., & Maier, L. (2021) · Molecular Systems Biology · doi:10.15252/msb.202010116 · Cited by 124
F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production
Sun, J., Tang, Q., Yu, S., Xie, M., Zheng, W., Chen, G., Yin, Y., Huang, X., Wo, K., Lei, H., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104444 · Cited by 121
Theranostic nanoparticles with disease-specific administration strategies
Zhang, P., Li, Y., Tang, W., Zhao, J., Jing, L., & McHugh, K. J. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101335 · Cited by 120
Chiral nanoparticle-remodeled gut microbiota alleviates neurodegeneration via the gut–brain axis
Guo, X. L., Li, C., Zhang, J., Sun, M., Xu, J., Xu, C., Kuang, H., & Xu, L. (2023) · Nature Aging · doi:10.1038/s43587-023-00516-9 · Cited by 119
Intracellular bacteria in cancer—prospects and debates
Schorr, L., Mathies, M., Elinav, E., & Puschhof, J. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00446-9 · Cited by 116
Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer
Chen, L., Zhao, R., Shen, J., Liu, N., Zheng, Z., Yu, M., Zhu, J., Zhang, L., Wang, Y., Fang, H., et al. (2023) · Advanced Materials · doi:10.1002/adma.202306281 · Cited by 115
An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure
Zheng, D., Pan, P., Chen, K.-W., Fan, J., Li, C., Cheng, H. L., & Zhang, X. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0582-1 · Cited by 114
Self-citation
Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia
Iacucci, M., Santacroce, G., Majumder, S., Morael, J., Zammarchi, I., Maeda, Y., Ryan, D., Sabatino, A. D., Rescigno, M., Aburto, M. R., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331579 · Cited by 110
Customized materials-assisted microorganisms in tumor therapeutics
Chen, Q., Qiao, J., Liu, X., Zhang, C., & Zhang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01571g · Cited by 109
Self-citation
The role of gut microbiota and metabolites in cancer chemotherapy
Li, S., Zhu, S., & Yu, J. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.11.027 · Cited by 109
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
Nandi, D., Parida, S., & Sharma, D. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2221452 · Cited by 103
Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating
Luo, H., Wu, F. Q., Wang, X., Lin, S., Zhang, M., Cao, Z., & Liu, J. (2023) · Materials Today · doi:10.1016/j.mattod.2023.01.001 · Cited by 102
Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression
Kong, X., Zhang, Y., Xiang, L., You, Y., Duan, Y., Zhao, Y.-Q., Li, S., Wu, R., Zhang, J., Zhou, L., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02817-8 · Cited by 101
Gut virome in inflammatory bowel disease and beyond
Tun, H. M., Peng, Y., Massimino, L., Sin, Z. Y., Parigi, T. L., Facoetti, A., Rahman, S., Danese, S., & Ungaro, F. (2023) · Gut · doi:10.1136/gutjnl-2023-330001 · Cited by 101
Phage Products for Fighting Antimicrobial Resistance
Huang, Y., Wang, W., Zhang, Z., Gu, Y., Huang, A., Wang, J., & Hao, H. (2022) · Microorganisms · doi:10.3390/microorganisms10071324 · Cited by 100
Unraveling the Role of the Human Gut Microbiome in Health and Diseases
Khalil, M., Ciaula, A. D., Mahdi, L., Jaber, N., Palo, D. M. D., Graziani, A., Baffy, G., & Portincasa, P. (2024) · Microorganisms · doi:10.3390/microorganisms12112333 · Cited by 100
Microbiota-driven mechanisms at different stages of cancer development
Ivleva, E., & Grivennikov, S. I. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100829 · Cited by 99
The microbiome in cancer
Lin, A., Xiong, M., Jiang, A., Huang, L., Wong, H. Z. H., Feng, S., Zhang, C., Yu, H., Chen, L., Chi, H., et al. (2025) · iMeta · doi:10.1002/imt2.70070 · Cited by 99
Effects of microbiota on anticancer drugs: Current knowledge and potential applications
Huang, J., Liu, W., Kang, W., He, Y., Yang, R., Mou, X., & Zhao, W. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104197 · Cited by 97
Chemical reaction-mediated covalent localization of bacteria
Luo, H., Chen, Y., Kuang, X., Wang, X., Yang, F., Cao, Z., Wang, L., Lin, S., Wu, F. Q., & Liu, J. (2022) · Nature Communications · doi:10.1038/s41467-022-35579-6 · Cited by 97
Engineered Living Materials for Advanced Diseases Therapy
Xue, D. Q., Wu, W. H., Pan, P., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202304963 · Cited by 95
Self-citation
Phage-based delivery systems: engineering, applications, and challenges in nanomedicines
Wang, H., Yang, Y., Xu, Y. S., Chen, Y., Zhang, W., Liu, T., Chen, G., & Wang, K. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02576-4 · Cited by 94
The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications
Bai, G.-H., Lin, S., Hsu, Y., & Chen, S.-Y. (2022) · Viruses · doi:10.3390/v14020278 · Cited by 93
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy
Yue, B., Gao, R., Wang, Z., & Dou, W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.710945 · Cited by 91
Neisseria meningitidis Opca Protein/MnO2 Hybrid Nanoparticles for Overcoming the Blood–Brain Barrier to Treat Glioblastoma
Dong, C., Huang, Q., Cheng, H. L., Zheng, D., Hong, S., Yan, Y. Q., Niu, M., Xu, J., & Zhang, X. (2022) · Advanced Materials · doi:10.1002/adma.202109213 · Cited by 90
Self-citation
MnO 2 -Based nanosystems for cancer therapy
Wen, J., Yang, K., & Sun, S. (2020) · Chemical Communications · doi:10.1039/d0cc02782k · Cited by 89
Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes
Perillo, F., Amoroso, C., Strati, F., Giuffrè, M. R., Díaz‐Basabe, A., Lattanzi, G., & Facciotti, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155389 · Cited by 88
Shining Light on Human Gut Bacteriophages
Guerin, E., & Hill, C. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00481 · Cited by 88
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Fidelle, M., Yonekura, S., Picard, M., Cogdill, A. P., Hollebecque, A., Roberti, M. P., & Zitvogel, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.600886 · Cited by 87
Engineering the gut microbiome
Bai, X., Huang, Z., Duraj‐Thatte, A., Ebert, M., Zhang, F., Burgermeister, E., Liu, X., Scott, B. M., Li, G., & Zuo, T. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00072-2 · Cited by 85
Biological chemotaxis-guided self-thermophoretic nanoplatform augments colorectal cancer therapy through autonomous mucus penetration
Wang, Z., Chu, M., Yin, N., Huang, W., Liu, W., Zhang, Z., Liu, J., & Shi, J. (2022) · Science Advances · doi:10.1126/sciadv.abn3917 · Cited by 84
In Situ Bioorthogonal Conjugation of Delivered Bacteria with Gut Inhabitants for Enhancing Probiotics Colonization
Song, W., Yao, W.-Q., Chen, Q., Zheng, D., Han, Z., & Zhang, X. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00533 · Cited by 83
Self-citation
The Dual Role of Serotonin in Colorectal Cancer
Kannen, V., Bäder, M., Sakita, J. Y., Uyemura, S. A., & Squire, J. A. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.008 · Cited by 81
MXene–laden bacteriophage: A new antibacterial candidate to control bacterial contamination in water
Mansoorianfar, M., Shahin, K., Najafabadi, A. H., & Pei, R. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.133383 · Cited by 81
Orally Administrated Hydrogel Harnessing Intratumoral Microbiome and Microbiota-Related Immune Responses for Potentiated Colorectal Cancer Treatment
Li, L., He, S., Liao, B., Wang, M., Lin, H., Hu, B., Lan, X., Shu, Z., Zhang, C., Yu, M., et al. (2024) · Research · doi:10.34133/research.0364 · Cited by 79
Dual Gate‐Controlled Therapeutics for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Cancer Immunotherapy
Zhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102059 · Cited by 79
Self-citation
Delivering living medicines with biomaterials
Harimoto, T., Jung, W., & Mooney, D. J. (2025) · Nature Reviews Materials · doi:10.1038/s41578-024-00766-y · Cited by 79
A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy
Zheng, D., Gao, F., Qian, C., Bao, P., Dong, X., Fan, J., Song, W. L., Zeng, X., Cheng, S., & Zhang, X. (2020) · Nature Communications · doi:10.1038/s41467-020-15927-0 · Cited by 77
Self-citation
Rethinking phage-bacteria-eukaryotic relationships and their influence on human health
Wahida, A., Tang, F., & Barr, J. J. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.007 · Cited by 76
An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria
Chen, L., Kang, Z., Shen, J., Zhao, R., Miao, Y., Zhang, L., Zheng, Z., Zhang, Z., Liu, N., Wang, C., et al. (2024) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.06.016 · Cited by 76
Fusobacterium nucleatum: ecology, pathogenesis and clinical implications
Jiang, S., Chen, Y., & Fang, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01237-z · Cited by 76
A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy
Wan, T., Pan, Q., Liu, C., Guo, J., Li, B., Yan, X., Cheng, Y., & Ping, Y. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c03708 · Cited by 73
Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases
Zhang, Q., Liu, Y., Li, Y., Bai, G., Pang, J., Wu, M., Li, J., Zhao, X., & Xia, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2508426 · Cited by 73
The Role of Bacteriophages in the Gut Microbiota: Implications for Human Health
Emencheta, S. C., Olovo, C. V., Eze, O. C., Kalu, C. F., BEREBON, D. P., Onuigbo, E. B., Vila, M. M. D. C., Balcão, V. M., & Attama, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102416 · Cited by 68
Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance
Dadgar-Zankbar, L., Elahi, Z., Shariati, A., Khaledi, A., Razavi, S., & Khoshbayan, A. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01909-y · Cited by 68
Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer
Gao, R., Zhu, Y., Kong, C., Xia, K., Li, H., Zhu, Y., Zhang, X., Liu, Y., Zhong, H., Yang, R., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.657867 · Cited by 66
Self-citation
Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy
Zhu, R., Lang, T., Yan, W., Zhu, X. G., Huang, X. Y., Yin, Q., & Li, Y. (2021) · Advanced Science · doi:10.1002/advs.202003542 · Cited by 65
Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance
Chen, L., Zhao, R., Kang, Z., Cao, Z., Liu, N., Shen, J., Wang, C., Pan, F., Zhou, X., Liu, Z., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.028 · Cited by 65
Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis
Wang, H., Mu, J.-K., Chen, Y., Liu, Y., Li, X., Li, H., & Cao, P. (2024) · Advanced Science · doi:10.1002/advs.202308235 · Cited by 65
Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics
Inamura, K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.006 · Cited by 63
Large-scale phage cultivation for commensal human gut bacteria
Shen, J., Zhang, J., Mo, L., Li, Y., Li, Y., Li, C., Kuang, X., Tao, Z., Qu, Z., Wu, L. H., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.013 · Cited by 62
The Enemy of My Enemy: New Insights Regarding Bacteriophage–Mammalian Cell Interactions
Bodner, K., Melkonian, A. L., & Covert, M. W. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.10.014 · Cited by 62

Authors: Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z.
Affiliations: Wuhan University (CN)
Corresponding author: Zhang, Xian-Zheng
ORCID: Dong, Xue
Pan, Pei
Chen, Ke-Wei
Fan, Jin-Xuan
Cheng, Si-Xue
Zhang, Xian-Zheng
Venue: Nature Biomedical Engineering
Publisher: Springer Science and Business Media LLC
Published: 2019-07-22
Volume: 3
Issue: 9
Pages: 717-728
ISSN: 2157-846X (ISSN-L)
DOI: 10.1038/s41551-019-0423-2
OpenAlex: W2963121075
Semantic Scholar: 94cc03369015ffa0b01be1420acac9b81fce02ac
Cited by: 495
References: 37
Citations by year: 2026: 77 · 2025: 92 · 2024: 96 · 2023: 87 · 2022: 53 · 2021: 45 · 2020: 39 · 2019: 5
FWCI: 18.93
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: colorectal cancer, gut microbiota, phage therapy, Fusobacterium nucleatum, irinotecan, dextran nanoparticles, chemotherapy response, butyrate-producing bacteria, orthotopic tumor model, piglet model
MeSH terms: Gastrointestinal Microbiome, Irinotecan, Animals, Antineoplastic Agents, Bacteria, Bacteriophages, Butyrates, Colonic Neoplasms, Dextrans, Disease Models, Animal, Drug Therapy, Immunoglobulins, Male, Mice, Inbred C57BL, Colorectal Neoplasms, Fusobacterium nucleatum, Cell Line, Tumor, Cell Proliferation, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks